JP2023538419A5 - - Google Patents

Info

Publication number
JP2023538419A5
JP2023538419A5 JP2023512647A JP2023512647A JP2023538419A5 JP 2023538419 A5 JP2023538419 A5 JP 2023538419A5 JP 2023512647 A JP2023512647 A JP 2023512647A JP 2023512647 A JP2023512647 A JP 2023512647A JP 2023538419 A5 JP2023538419 A5 JP 2023538419A5
Authority
JP
Japan
Application number
JP2023512647A
Other languages
Japanese (ja)
Other versions
JPWO2022038261A5 (https=
JP2023538419A (ja
JP7794807B2 (ja
Filing date
Publication date
Priority claimed from EP20382764.7A external-priority patent/EP3957308A1/en
Application filed filed Critical
Publication of JP2023538419A publication Critical patent/JP2023538419A/ja
Publication of JPWO2022038261A5 publication Critical patent/JPWO2022038261A5/ja
Publication of JP2023538419A5 publication Critical patent/JP2023538419A5/ja
Application granted granted Critical
Publication of JP7794807B2 publication Critical patent/JP7794807B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023512647A 2020-08-21 2021-08-20 気道疾患の治療に使用するための(1r,3s)-3-((5-シアノ-4-フェニルチアゾール-2-イル)カルバモイル)シクロペンタン-1-カルボン酸およびその誘導体 Active JP7794807B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20382764.7 2020-08-21
EP20382764.7A EP3957308A1 (en) 2020-08-21 2020-08-21 (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseases
PCT/EP2021/073133 WO2022038261A1 (en) 2020-08-21 2021-08-20 (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseases

Publications (4)

Publication Number Publication Date
JP2023538419A JP2023538419A (ja) 2023-09-07
JPWO2022038261A5 JPWO2022038261A5 (https=) 2024-07-29
JP2023538419A5 true JP2023538419A5 (https=) 2024-07-29
JP7794807B2 JP7794807B2 (ja) 2026-01-06

Family

ID=72234795

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023512647A Active JP7794807B2 (ja) 2020-08-21 2021-08-20 気道疾患の治療に使用するための(1r,3s)-3-((5-シアノ-4-フェニルチアゾール-2-イル)カルバモイル)シクロペンタン-1-カルボン酸およびその誘導体

Country Status (20)

Country Link
US (1) US20230321053A1 (https=)
EP (2) EP3957308A1 (https=)
JP (1) JP7794807B2 (https=)
KR (1) KR20230054444A (https=)
CN (1) CN115942933A (https=)
AU (1) AU2021327728A1 (https=)
BR (1) BR112023002778A2 (https=)
CA (1) CA3190081A1 (https=)
DK (1) DK4199922T3 (https=)
ES (1) ES3001104T3 (https=)
FI (1) FI4199922T3 (https=)
HR (1) HRP20241621T1 (https=)
HU (1) HUE069338T2 (https=)
LT (1) LT4199922T (https=)
MX (1) MX2023002156A (https=)
PL (1) PL4199922T3 (https=)
PT (1) PT4199922T (https=)
RS (1) RS66263B1 (https=)
SI (1) SI4199922T1 (https=)
WO (1) WO2022038261A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102460040B1 (ko) 2016-04-27 2022-11-01 애브비 인코포레이티드 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법
US12162940B2 (en) 2021-05-05 2024-12-10 Immatics Biotechnologies Gmbh BMA031 antigen binding polypeptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070219223A1 (en) 2006-03-07 2007-09-20 Endacea, Inc. Compositions and methods for treating respiratory disorders
ES2331220B1 (es) 2007-10-02 2010-09-23 Palobiofarma, S.L. Nuevos compuestos como antagonistas de los receptores a1 de adenosina.
KR20160061352A (ko) 2013-10-15 2016-05-31 메디뮨 엘엘씨 벤랄리주맙을 사용하여 만성 폐쇄성 폐 질환을 치료하는 방법
UA122670C2 (uk) * 2014-09-08 2020-12-28 Сефалон, Інк. Спосіб лікування еозинофільної астми у пацієнта
ES2676535B1 (es) * 2017-01-20 2019-04-29 Palobiofarma Sl Moduladores de los receptores a3 de adenosina
LT3592734T (lt) 2017-03-06 2021-07-26 Palobiofarma, S.L. (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksirūgšties amino druska

Similar Documents

Publication Publication Date Title
CN305526831S (https=)
CN305843528S (https=)
CN305578621S (https=)
CN305579503S (https=)
CN305605348S (https=)
CN305656462S (https=)
CN305680838S (https=)
CN305691070S (https=)
CN305710984S (https=)
CN305727317S (https=)
CN305740600S (https=)
CN305741514S (https=)
CN305761056S (https=)
CN305762483S (https=)
CN305766338S (https=)
CN305767667S (https=)
CN305784017S (https=)
CN305789304S (https=)
CN305789626S (https=)
CN305792165S (https=)
CN305793832S (https=)
CN305794911S (https=)
CN305802719S (https=)
CN305810289S (https=)
CN305829352S (https=)